Clinical Trial Update: Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating absorption, metabolism, and excretion after a single dose of Ferriprox (deferiprone) in patients with sickle cell disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• FERRIPROX (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-07-24